Cargando…
Screening and personalizing nootropic drugs and cognitive modulator regimens in silico
The go-to cognitive enhancers of today are those that are widely available rather than optimal for the user, including drugs typically prescribed for treatment of ADHD (e.g., methylphenidate) and sleep disturbances such as narcolepsy (modafinil). While highly effective in their intended therapeutic...
Autores principales: | Jellen, Leslie C., Aliper, Alexander, Buzdin, Anton, Zhavoronkov, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319391/ https://www.ncbi.nlm.nih.gov/pubmed/25705179 http://dx.doi.org/10.3389/fnsys.2015.00004 |
Ejemplares similares
-
In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state
por: Aliper, Alexander, et al.
Publicado: (2016) -
A method for predicting target drug efficiency in cancer based on the analysis of signaling pathway activation
por: Artemov, Artem, et al.
Publicado: (2015) -
Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs
por: Zhavoronkov, Alex, et al.
Publicado: (2014) -
Pathway activation profiling reveals new insights into Age-related Macular Degeneration and provides avenues for therapeutic interventions
por: Makarev, Evgeny, et al.
Publicado: (2014) -
Genetics and epigenetics of aging and longevity
por: Moskalev, Alexey A, et al.
Publicado: (2014)